Cargando…

Proton therapy versus photon radiation therapy for the management of a recurrent desmoid tumor of the right flank: a case report

Desmoid tumors are benign mesenchymal tumors with a strong tendency for local recurrence after surgery. Radiotherapy improves local control following incomplete resection, but nearby organs at risk may limit the dose to the target volume. The patient in this report presented with a recurrent desmoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Kil, Whoon Jong, Nichols, R Charles, Kilkenny, John W, Huh, Soon Y, Ho, Meng Wei, Gupta, Pratibha, Marcus, Robert B, Indelicato, Daniel J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542192/
https://www.ncbi.nlm.nih.gov/pubmed/23098082
http://dx.doi.org/10.1186/1748-717X-7-178
Descripción
Sumario:Desmoid tumors are benign mesenchymal tumors with a strong tendency for local recurrence after surgery. Radiotherapy improves local control following incomplete resection, but nearby organs at risk may limit the dose to the target volume. The patient in this report presented with a recurrent desmoid tumor of the right flank and underwent surgery with microscopically positive margins. Particular problems presented in this case included that the tumor bed was situated in close proximity to the liver and the right kidney and that the right kidney was responsible for 65% of the patient’s renal function. Intensity-modulated radiation therapy plans delivering 54 Gy necessarily exposed the right kidney to a V(18) of 98% and the liver to a V(30) of 55%. Proton therapy plans significantly reduced the right kidney V(18) to 32% and the liver V(30) to 28%. In light of this, the proton plan was utilized for treatment of this patient. Proton therapy was tolerated without gastrointestinal discomfort or other complaints. Twenty-four months after initiation of proton therapy, the patient is without clinical or radiographic evidence of disease recurrence. In this setting, the improved dose distribution associated with proton therapy allowed for curative treatment of a patient who arguably could not have been safely treated with intensity-modulated radiation therapy or other methods of conventional radiotherapy.